Bayer sells animal health unit to Elanco for $7.6bn

Germany’s Bayer has agreed to sell its animal health business to US firm Elanco for $7.6bn in cash and equity. Analysts reckon this will be positive for Bayer's credit quality, after its litigation-shrouded Monsanto acquisition last year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: